Home LiteratureArticle Details
PMID: 63850 Published · ppublish English Comparative Study Journal Article

Penicillinase-producing Gonococci in Liverpool.

Lancet (London, England) ·Vol. 2 ·No. 8000 ·1976-12-25 ·Pages 1379-82

Percival A, Rowlands J, Corkill JE, Alergant CD, Arya OP, Rees E, Annels EH

Abstract

Gonococci, which had acquired a TEM-type of penicillinase widely distributed among gram-negative bacilli, appeared in February, 1976, and soon accounted for 9% of isolates at a clinic in Liverpool. In 45 patients infected by such gonococci, the frequency of complications did not suggest reduced communicability or invasiveness, and usual forms of treatment with penicillins always failed. Spectinomycin succeeded in 21 (95%) of 22 patients treated, blt tetracyclines succeeded in only 13 (68%) of 19. Appropriate laboratory tests for recognising penicillinase-producing gonococci must be used since such gonococci have already been transferred to other parts of the U.K. Penicillinase-stable cephalosporins were active in vitro and could prove to be the future treatment of choice.

MeSH Terms
Cephalosporins/pharmacology,therapeutic use Female Gonorrhea/drug therapy Humans Male Microbial Sensitivity Tests Neisseria gonorrhoeae/drug effects,enzymology Penicillin G/antagonists & inhibitors Penicillin Resistance Penicillinase/biosynthesis,pharmacology Penicillins/pharmacology,therapeutic use
Chemicals
Cephalosporins Penicillins Penicillinase Penicillin G
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Percival A
Rowlands J
Corkill J E
Alergant C D
Arya O P
Rees E
Annels E H
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1976-12-25
Pages
1379-82
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]